[1]
D. K. Chourasia, D. K. Girendrae, D. V. Patel, and D. M. Khare, “TO ASSESS THE ADVERSE EFFECT PROFILE OF SECOND LINE DRUG IN TB PATIENTS”, IJMBS, vol. 3, no. 8, pp. 95-97, Aug. 2019.